Learn more: PMC Disclaimer | PMC Copyright Notice
Identification and Characterization of Genes Required for 5-Hydroxyuridine Synthesis in Bacillus subtilis and Escherichia coli tRNA
aAssociated Data
Modified nucleotides in tRNA serve to optimize both its structure and function for accurate translation of the genetic code. The biosynthesis of these modifications has been fertile ground for uncovering unique biochemistry and metabolism in cells. In this work, genes that are required for a novel anaerobic hydroxylation of uridine at the wobble position of some tRNAs are identified in both Bacillus subtilis and Escherichia coli. These genes code for Fe-S cluster proteins, and their deletion reduces the levels of the hydroxyuridine by 50% in both organisms. Additional genes required for Fe-S cluster and prephenate biosynthesis and a previously described ferredoxin gene all display a similar reduction in hydroxyuridine levels, suggesting that still other genes are required for the modification.
ABSTRACT
In bacteria, tRNAs that decode 4-fold degenerate family codons and have uridine at position 34 of the anticodon are typically modified with either 5-methoxyuridine (mo5U) or 5-methoxycarbonylmethoxyuridine (mcmo5U). These modifications are critical for extended recognition of some codons at the wobble position. Whereas the alkylation steps of these modifications have been described, genes required for the hydroxylation of U34 to give 5-hydroxyuridine (ho5U) remain unknown. Here, a number of genes in Escherichia coli and Bacillus subtilis are identified that are required for wild-type (wt) levels of ho5U. The yrrMNO operon is identified in B. subtilis as important for the biosynthesis of ho5U. Both yrrN and yrrO are homologs to peptidase U32 family genes, which includes the rlhA gene required for ho5C synthesis in E. coli. Deletion of either yrrN or yrrO, or both, gives a 50% reduction in mo5U tRNA levels. In E. coli, yegQ was found to be the only one of four peptidase U32 genes involved in ho5U synthesis. Interestingly, this mutant shows the same 50% reduction in (m)cmo5U as that observed for mo5U in the B. subtilis mutants. By analyzing the genomic context of yegQ homologs, the ferredoxin YfhL is shown to be required for ho5U synthesis in E. coli to the same extent as yegQ. Additional genes required for Fe-S biosynthesis and biosynthesis of prephenate give the same 50% reduction in modification. Together, these data suggest that ho5U biosynthesis in bacteria is similar to that of ho5C, but additional genes and substrates are required for complete modification.
IMPORTANCE Modified nucleotides in tRNA serve to optimize both its structure and function for accurate translation of the genetic code. The biosynthesis of these modifications has been fertile ground for uncovering unique biochemistry and metabolism in cells. In this work, genes that are required for a novel anaerobic hydroxylation of uridine at the wobble position of some tRNAs are identified in both Bacillus subtilis and Escherichia coli. These genes code for Fe-S cluster proteins, and their deletion reduces the levels of the hydroxyuridine by 50% in both organisms. Additional genes required for Fe-S cluster and prephenate biosynthesis and a previously described ferredoxin gene all display a similar reduction in hydroxyuridine levels, suggesting that still other genes are required for the modification.
INTRODUCTION
Organisms from all kingdoms of life take advantage of redundancy patterns in the genetic code to reduce the number of unique tRNAs required to translate the 61 sense codons (1). To do this, tRNAs utilize wobble pairing (2) with a G or U at position 34, the first position of the anticodon, to recognize U or G, respectively, at position 3 of the codon. In addition, modified bases are heavily employed at position 34 to either extend or restrict wobble capacity beyond standard wobble rules (3,–6). For example, eukaryotes invariably use inosine in I34N35N36 anticodons to extend pairing to A and C, while bacteria rely mostly on modified uridines in the 4-fold degenerate (four box) amino acid codon families to extend pairing to U and C (7, 8). Such modifications allow organisms to further reduce the number of required tRNAs. A recent analysis of bacterial tRNA usage and evolution suggests that a highly dynamic population of mandatory and “auxiliary” tRNAs exists in bacterial species and that these populations fluctuate via both mutation and horizontal gene transfer (9).
In Escherichia coli, tRNAs that decode the four degenerate codon family amino acids Ala, Pro, Thr, Val, Ser, and Leu have a hypermodified U34 substituted at the 5 position with a 5-methoxycarbonylmethoxy (5-oxyacetic acid methyl ester) (mcmo5) group (Fig. 1) (8, 9). The ester moiety is unstable to alkali and even at pH 7.5 results in degradation with a half-life of 20 h (10). Both the fully modified 5-methoxycarbonylmethoxyuridine (mcmo5U) (10) and its biosynthetic precursor 5-carbonylmethoxyuridine (cmo5U) (11) are found in vivo, with mcmo5U predominating in , , , and , while cmo5U predominates in and (12). The amount of methyl ester modification increases significantly with growth phase in in E. coli (12). Both biochemical (13) and structural work (14) have indicated that tRNAs with the (m)cmo5U modification are able to not only decode A3 and G3 at the third codon position but also bind to U3 and C3 containing codons (3). This expanded role was first verified in vivo by the observation that a single is sufficient for recognizing all four codons in a Salmonella enterica serovar Typhimurium mutant lacking the other two proline tRNA genes (15). Nasvall et al. also found in later work that (m)cmo5U-enhanced codon recognition in vivo is highly context dependent, such that in S. Typhimurium, U3- and C3-containing codons can be decoded by (m)cmo5U-modified , , and , while for the Leu, Ser, and Thr codon families, they cannot (16). The most surprising result from this work is that cmo5U was found to be required for efficient classic wobble decoding of G3 as well. Structurally, the carboxymethyl group of cmo5U is required for maximum decoding efficiency in vivo, as mutants which contain only 5-hydroxyuridine (ho5U) at position 34 display a significant growth defect in many cases where the (m)cmo5U tRNA is the sole isoacceptor (16). Crystal structures of cmo5U-modified tRNAVal anticodon stem loop RNA (ACSLVal) bound to different codons on the ribosome (14) show that the modification promotes several stabilizing interactions that preorganize the ACSL for interaction with codons. These include a C3′-endo conformation of the ribose and hydrogen bonding from the ether oxygen of cmo5U to the ribose 3′-OH of highly conserved U33. Earlier studies showed that the alkyl group of mo5U shifts the tautomeric equilibrium toward the enol (lactim) form at C4 of the uridine ring (17). Together these effects promote Watson Crick, not wobble, pairing geometry to G3 ending codons via the enol form of cmo5U, as well as conformational stabilization of the anticodon loop necessary to entropically compensate for weak hydrogen bonding with U3 and C3 (14).
Biosynthesis of ho5U derivatives in bacterial tRNA. In E. coli and other gammaproteobacteria, CmoA and CmoB convert AdoMet to carboxy-AdoMet and transfer the carboxymethyl group to ho5U to give cmo5U. The latter is then methylated by CmoM to give the terminal modification mcmo5U. In B. subtilis and most other bacteria, ho5U is methylated directly by the recently identified TrmR (YrrM) methyltransferase (22). The genes required for ho5U synthesis have yet to be described and are the subject of this work.
While (m)cmo5U is found mainly in gammaproteobacteria (12), Bacillus subtilis and possibly most other bacteria utilize the structurally simpler 5-methoxyuridine (mo5U) at the same position in the respective tRNAs (18) (Fig. 1). As shown in Fig. 1, the biosynthesis of both modifications is believed to begin with a novel anaerobic hydroxylation at C5 (4). Seminal work by Björk and coworkers showed that the biosynthesis of cmo5U in S. Typhimurium is dependent on two methyltransferase-like genes, cmoA and cmoB, both of which were required for cmo5U production (15), although the exact mechanism of constructing the carboxymethyl group was not clear. An interesting clue was provided by their demonstration of an additional requirement for chorismate or a downstream metabolite. This metabolite was required for both carboxymethyl formation and for full hydroxylation activity (19). Structural studies of CmoA later showed that the chorismate-derived metabolite is prephenic acid, which is decarboxylated to provide CO2 in the CmoA active site (20). The nascent CO2 then adds to an unprecedented ylide form of S-adenosylmethionine (AdoMet) to give the novel product carboxymethyl-AdoMet. CmoB then transfers the carboxymethyl group of carboxy-AdoMet directly to ho5U to give cmo5U. The cmoM gene was recently identified by Sakai et al. as coding for the methyltransferase required for methylation of the carboxylic acid in most cmo5U-containing tRNAs (12).
While genes have been identified for the biosynthesis of the alkylation steps in the ho5U-derived modification (xo5U) pathways, those involved in the hydroxylation have remained unknown. Kimura et al. recently reported that the hydroxylation step in the synthesis of structurally similar 5-hydroxycytidine (ho5C) in rRNA is dependent on the rlhA gene (formerly ydcP) (21). RlhA is a member of a group of proteins found in bacteria annotated as U32 peptidases (NCBI conserved domain accession number COG0826) but with no experimentally known function. These authors also showed that the ho5C modification requires Fe-S cluster biosynthetic machinery and that prephenic acid is also the likely source of the oxygen of the hydroxyl. In the work reported here, the genes required for the biosynthesis of ho5U in tRNA in both E. coli and B. subtilis have been identified and the corresponding mutants characterized. The findings are consistent with results for ho5C biosynthesis, with the interesting exception that (as Björk and coworkers demonstrated) for ho5U other genes and possibly other substrates are required to give full ho5U modification levels in tRNA. In addition, a novel low potential ferredoxin, YfhL, of previously unknown function, has been identified as a requirement for ho5U synthesis in E. coli. Differences in the genetic organization, as well as the mechanistic role of the orthologous proteins in E. coli versus B. subtilis are presented and discussed.
RESULTS
The yrrMNO operon contains genes required for wild-type levels of ho5U biosynthesis in B. subtilis.
A bioinformatics approach was initially used with E. coli cmoB as query to search for genes required for ho5U synthesis. This approach led to the identification of the yrrMNO operon in B. subtilis via the likely terminal methyltransferase YrrM. High-pressure liquid chromatography (HPLC) analysis of enzymatic digests of bulk tRNA extracted from a yrrM deletion strain (Bacillus Genetic Stock Center) showed a complete absence of mo5U (Fig. 3A) and the appearance of ho5U in the HPLC trace indicating yrrM coded for the methyltransferase. While this work was in progress, Ryu et al. published this result along with the crystal structure of the protein and named the gene trmR (22) (Fig. 1). As shown in Fig. 2A, located downstream of the yrrM gene are two additional genes, yrrN and yrrO, that are adjacent and predicted to be included in the operon. Both YrrN and YrrO are annotated as U32 peptidases or collagenases (23). However, iterative PSI-BLAST (24) searches showed that the proteins had multiple conserved cysteines, as shown in Fig. 2B, and also weak homology to Fe-S cluster-containing proteins in both bacteria and archaea. In addition, Kimura et al. (21) published that the peptidase U32 gene rlhA was required for ho5C synthesis in E. coli rRNA. Thus, it was likely that one or both of these genes were required for ho5U synthesis in tRNA in B. subtilis.
(A) Organization of the two peptidase U32 genes in B. subtilis and four genes in E. coli. Numbers indicate corresponding protein amino acid length. (B) Clustal-omega amino acid alignment of peptidase U32 homologs from E. coli and B. subtilis. Putative Fe-S cluster cysteines are highlighted in yellow although there are other cysteines in the region. Amino acids that differ from cysteine in the conserved positions are shown in red (YhbU is the exception in which an adjacent cysteine has been included as a potential Fe-S ligand).
(A) Representative HPLC analysis of mo5U levels of B subtilis wt and mutant strains. The first trace shows synthetic standards of modified nucleosides relevant to this work. Total tRNA isolated from each strain (12.5 μg) is enzymatically digested to nucleosides and analyzed by HPLC with detection by absorbance at 280 nm. (B) Quantitative effect of selected B. subtilis peptidase U32 gene deletions on levels of mo5U in purified total tRNA based on the ratio of peak integration relative to pseudouridine (Ψ). ***, P < 0.001 (unpaired t test); **, P < 0.01 compared to wt strain; ns = no statistically significant difference between levels in these strains.
Surprisingly, analysis of tRNA from both the yrrN and yrrO single mutants still showed the presence of mo5U; however, as shown in Fig. 3, careful quantitation of the peak areas of mo5U relative to pseudouridine (Ψ) showed that the mo5U levels were reduced by ∼50% in both mutant strains relative to the wild-type (wt) strain (Fig. 3B). Complementation of both the yrrN (not shown) and yrrO (Fig. 3B) mutants using the pLIKErep expression plasmid (25) with bacitracin induced expression of yrrN and yrrO, respectively, and showed full complementation of mo5U to wt levels. The possibility that yrrN and yrrO are paralogs and each is required for 50% of ho5U biosynthesis was quickly proven false by the successful preparation of a yrrNO double mutant. The method of Koo et al. (26) was used to replace the adjacent yrrNO genes with either a kanamycin or erythromycin resistance gene via double crossover. These mutants were viable with no observable growth defects in rich medium (LB) and, as shown in Fig. 3A and quantitated in Fig. 3B, showed no further reduction in mo5U levels when compared to either the yrrN or yrrO single mutants. Complementation studies showed that both yrrN and yrrO were alone not able to complement the double mutant. This was intriguing because it indicates that the YrrN and YrrO proteins may be required together for the same step in mo5U synthesis and that this step is not sufficient to account for all of the mo5U synthesis.
The yegQ gene is the only peptidase U32 gene that is involved in the synthesis of cmo5U in E. coli.
Because deletion of yrrO or yrrN or both resulted in the same 50% reduction in mo5U levels in B. subtilis, attention was turned toward the analogous modification in E. coli. In this organism, both mcmo5U and cmo5U are present and functional, depending on the tRNA species (12). The ester of mcmo5U is significantly hydrolyzed to cmo5U during usual enzymatic digestion for HPLC analysis (12) and can be completely hydrolyzed in 4 h at pH 8.3, which simplifies analysis. For the Keio collection reference E. coli strain BW5113 (27), the level of cmo5U in bulk tRNA was found to be approximately 0.17 mol/mol tRNA, 70% lower than the mo5U level in B. subtilis 168 (0.24 mol/mol tRNA). This lower value for E. coli is expected based on lower copy numbers of mcmo5U-modified tRNA genes in the E. coli genome (12 copies in E. coli versus 18 copies in B. subtilis) (1). As recently described by Kimura et al. (21) and shown in Fig. 2, E. coli contains four peptidase U32 genes as follows: rlhA (ydcP), yegQ, and a putative operon containing the two adjacent genes yhbU and yhbV. The rlhA, yegQ, and yhbU mutants were obtained via the Keio collection (via E. coli Genetic Stock Center), while the yhbV deletion strain was prepared via the method of Datsenko and Wanner (28) by replacement of yhbV with the cat gene from plasmid pKD3 (Table 2). As shown in Fig. 4, analysis of the four single gene deletion strains for cmo5U levels shows that only yegQ has a reduced level of cmo5U compared to that of the wt. Surprisingly, the level of cmo5U in this strain is reduced by the same 50%, within experimental error, as that of the yrrN and yrrO mutants in B. subtilis. To confirm this result, we reconstructed the yegQ gene deletion mutant from the isogenic wt strain by gene replacement with the cat gene and also removed the antibiotic markers and observed the same levels of reduced cmo5U in both of these strains. Complementation with wt yegQ cloned in the arabinose-inducible plasmid pBAD33 resulted in l-arabinose-dependent rescue of the reduced cmo5U levels (Fig. 4). Extended growth of the yegQ mutant strain overnight did not result in increased levels of cmo5U (data not shown). Mutation of any of the four YegQ cysteines (C170, C177, C193, and C197) that are conserved with YrrO and RlhA (Fig. 2B) eliminates restoration of cmo5U to wt levels. These data show that wt levels of cmo5U are dependent on expression of functional yegQ. To determine if the other homologous genes are able to synthesize the remaining cmo5U in the absence of yegQ, systematic double and triple mutants were constructed as well as the quadruple mutant lacking all four peptidase U32 genes. PCR analysis confirms that all four genes were deleted in this strain (see Fig. S1 in the supplemental material). Only combinations of gene deletions that include yegQ were found to have reduced cmo5U levels, and these levels were all reduced from wt by essentially the same amount within experimental error. The quadruple mutant still retained the same cmo5U levels as those of the yegQ mutant. To confirm that this peak is indeed cmo5U, a coinjection was conducted with pure synthetic cmo5U (Fig. 4A), and the material that eluted in that peak was analyzed by high-resolution mass spectrometry to have an exact mass that identifies it as cmo5U (calculated, 317.077206; found, 319.077560). All mutant combinations showed no significant growth defects in rich medium. Since the rlhA (ydcP) mutant was found to be absolutely required for ho5C synthesis in rRNA, these data suggest that other genes are required for the biosynthesis of ho5U at wt levels.
(A) HPLC analysis of cmo5U levels of various E. coli peptidase U32 gene deletion mutants analyzed as described for Fig. 3A. The last two panels show the ΔyegQ ΔyhbUV ΔrlhA quadruple mutant without and with coinjection of cmo5U standard. The cmo5U peak was also isolated from this mutant and verified for identity by high-resolution mass spectrometry. (B) Quantitative analysis of selected gene deletions and complementation of E. coli peptidase U32 gene deletions based on HPLC analyzed levels of cmo5U in purified total tRNA. ***, P < 0.001 (unpaired t test) compared to wt strain.
TABLE 2
Plasmids used in this study
| Plasmid | Characteristic(s) | Source or referencea |
|---|---|---|
| pBAD33 | l-Arabinose-induced expression | 41 |
| pETiteN-His | N-terminal His6 fusion, T7 promoter | Lucigen |
| pRhamN-His | N-terminal His6 fusion, rham-induced | Lucigen |
| pKD3 | Source of cat gene | CGSC (28) |
| pKD46 | λ red recombinase/bla gene | CGSC (28) |
| pCL433 | E. coli yegQ/pETiteN-His | This work |
| pCL455 | E. coli yegQ/pBAD33 | This work |
| pCL502 | B. subtilis yrrM/pBAD33 | This work |
| pCL512 | B. subtilis yrrN/pRham | This work |
| pCL513 | B. subtilis yrrO/pBAD33 | This work |
| pCL496 | E. coli yfhL/pBAD33 | This work |
| pLIKE-rep | B. subtilis replicative plasmid | BGSC |
| pCL504 | yrrN/pLIKE-rep | This work |
| pCL550 | yrrO/pLIKE-rep | This work |
| pCL506 | yegQ/pLIKE-rep | This work |
E. coli iscS mutant synthesizes cmo5U but at a reduced level.
An important finding from Kimura et al. (21) was that ho5C synthesis in rRNA in E. coli is significantly dependent on Fe-S cluster biogenesis, specifically for genes in the isc operon. This is consistent with the earlier mentioned PSI-BLAST results. For example, they observed the level of ho5C is ∼1% in iscU mutants at log phase. Similar to effects previously reported in isc mutants for the Fe-S cluster enzyme-dependent thionucleosides s2C and ms2i6A (29), the levels of ho5C increase significantly in stationary phase, which suggests auxiliary Fe-S synthesis (e.g., via genes in the suf operon) is able to provide Fe-S clusters to rlhA, albeit inefficiently. The effect is greatest for iscS mutants. To test if cmo5U levels behave similarly, the iscS deletion strain from the Keio collection was analyzed for cmo5U levels in tRNA. Figure 5A shows the HPLC analysis of tRNA modified nucleosides from this mutant. While the region between C and G shows the expected absence of s2C and mn5s2U at early log phase, cmo5U is clearly present, although at reduced levels. As shown in Fig. 5B, quantitative analysis shows that cmo5U levels are similar on average to those for the yegQ mutant and also increase slightly from log phase to saturation (P = 0.06). Consistent with the iscS mutant phenotype in E. coli, the thionucleoside s2C, which elutes just before cmo5U, is undetectable at log phase but increases to near wt levels after overnight incubation. These data suggest that like ho5C, ho5U synthesis is dependent at least in part on iscS catalyzed Fe-S cluster biosynthesis. However, unlike ho5C, there is either a greater intrinsic ability to synthesize cmo5U via the redundant Fe-S pathway, or other genes are required that can synthesize ho5U without significant Fe-S cluster protein activity.
Effects of other genes on xo5U levels. (A) HPLC analysis of iscS, yfhL, and aroD in E. coli. The iscS mutant lacks thionucleosides s2C and mnm5s2U and cmnm5s2U in this region but still retains cmo5U, which is decreased to a similar level as the yegQ mutant (shown in panel B). The overnight iscS mutant culture shows significant increases in s2C and some increase in cmo5U, similar to increases in other Fe-S-dependent modifications. The effect on cmo5U is not statistically significant due to variability in the log-phase data. An E. coli strain lacking the ferredoxin yfhL shows a similar HPLC spectrum as that of the yegQ mutant and a similar level of reduction in cmo5U (shown in panel B). In E. coli, shikimate pathway genes, such as aroD, are required for conversion of ho5U to cmo5U and for wt levels of ho5U, as previously reported (15, 19). Quantifying the level of ho5U shows the same reduction in ho5U as for cmo5U in the yegQ and yfhL mutants. (B) Quantitative analysis of HPLC data for E. coli aro, iscS, and yfhL mutants relative to those of the wt strain. *, the aroD strain lacks the ability to synthesize cmo5U from ho5U and thus the ratio reported here is for ho5U/Ψ. ***, P < 0.001 compared to wt (unpaired t test); **, P < 0.01 compared to wt; ns = no statistical significance among these strains or with the wt strain.
Effect of aro mutants on the levels of cmo5U in E. coli and mo5U in B. subtilis.
One of the most intriguing aspects of the cmo5U modification in tRNA was the observation that chorismic acid or a downstream metabolite not only was required for the synthesis of the methylene carbon of cmo5U but also was necessary for wt levels of ho5U (19). Kimura et al. (21) have recently provided strong evidence that prephenic acid is the metabolite required for ho5C synthesis in rRNA; thus, it is reasonable to suspect it is also utilized by YegQ in the synthesis of ho5U. HPLC analysis of an aroD E. coli mutant from the Keio collection showed the expected complete absence of cmo5U and the presence of ho5U at reduced levels (Fig. 5A), confirming the original results from Hagervall et al. in S. Typhimurium (19). When trmR (yrrM) from B. subtilis is expressed in the E. coli aroD mutant, complete conversion of the ho5U to mo5U is observed. The level of ho5U observed here is identical within experimental error to the level of cmo5U in the yegQ mutant, and all combinatorial mutants of peptidase U32 genes in which yegQ is deleted. Furthermore, an aroD yegQ double mutant also shows the same reduced level of ho5U (not shown). E. coli mutants in aroA, aroB, and aroC also show similar reductions in ho5U, which is the sole xo5U modification present. These data suggest that like rlhA in ho5C synthesis, yegQ is part of a pathway that likely utilizes prephenate for ho5U synthesis. Yet, unlike ho5C, the ho5U tRNA modification is not solely dependent on yegQ and prephenate, and other genes and substrates are likely involved.
Unlike in E. coli, the B. subtilis shikimate pathway late stage genes (aroK, aroE, and aroF) that convert shikimic acid to chorismic acid are required for viability (26). However, the aroD mutant for shikimate dehydrogenase has no paralog, and the deletion mutant is viable, although it has a slow growth phenotype. Analysis of total tRNA from the aroD deletion mutant BKK27340 shows a reduced level of mo5U that is essentially the same as that in the yrrN and yrrO mutants (Fig. 3B). The synthesis of mo5U by TrmR uses AdoMet and, thus, does not require prephenate; thus, the effect of the aroD mutation is solely expressed as a reduction in mo5U. Both pheA and tyrA mutants in B. subtilis were observed to have wt mo5U levels (data not shown). Thus, it is likely that B. subtilis also uses prephenate as the hydroxyl donor for partial ho5U synthesis, and similar to E. coli, there are other genes and/or substrates involved in the biosynthesis of this modification.
Identification of the low potential ferredoxin YfhL as a requirement for ho5U synthesis in E. coli.
Because deletion of all peptidase U32 genes in both E. coli and B. subtilis did not abolish ho5U synthesis in tRNA, other genes must be involved. To search for additional genes, the genomic context of peptidase U32 orthologs was analyzed in a wide range of bacteria using the BioCyc platform (30). The genomic neighborhood as well as the homology of these genes is highly variable among bacteria. In Gram-negative organisms, there is no proximity between the peptidase U32 genes and homologs of cmoA, cmoB, or cmoM. In Gram-positive organisms, there is some consistency with colocalization of yrrO orthologs with O-methyltransferases that are similar to trmR (yrrM), but otherwise no consistent theme emerges. A number of candidate genes located adjacent to peptidase U32 genes, which have orthologs in E. coli and B. subtilis and possibly relevant annotation, were analyzed, but the deletion strains showed no effects on cmo5U or mo5U levels, respectively. However, one candidate gene was intriguing due to its annotation as a small ferredoxin. A number of bacteria in the Gammaproteobacteria class have yegQ and/or yrrO orthologs that are adjacent to downstream ferredoxin genes. The ferredoxins may be relevant to ho5U synthesis since YegQ and its homologs likely bind Fe-S clusters. In E. coli, the most similar homolog is YfhL, a unique low potential ferredoxin of unknown function (31). To test this hypothesis, total tRNA was isolated from the E. coli yfhL deletion mutant (Keio strain JW2546). HPLC analysis of the digested tRNA showed an identically reduced level of cmo5U as the isogenic yegQ mutant (Fig. 5). The reduced level could be fully complemented by plasmid-based overexpression of yfhL. A similar search for homologs in B. subtilis did not result in a clear hit, which is not surprising given the known restricted presence of yfhL orthologs to gammaproteobacteria (32). These results suggest that one of the elusive physiological roles of YfhL in these organisms may be to provide electrons to an Fe-S cluster-bound YegQ to support ho5U formation. Construction of a yegQ yfhL double knockout showed cmo5U levels identical to those of each single mutant, indicating that both genes are likely required in the same pathway for cmo5U synthesis. E. coli YfhL was overexpressed and purified aerobically. Attempts to observe formation of a YegQ-YfhL complex by native gel analysis under aerobic conditions were unsuccessful. It is possible that these proteins interact only under anaerobic conditions or that each protein has a distinct role in ho5U synthesis that does not require direct interaction.
Analysis of mo5U levels of individual tRNAs in the B. subtilis yrrO mutant.
A 50% reduced level of mo5U in bulk tRNA from yrrO and yrrN mutants could be the result of a complete loss of ho5U in half of the substrate tRNAs or a partial loss of ho5U in all tRNAs, the sum of which leads to the observed 50% reduction. To find out which is more likely to be the case, individual tRNAs were purified from B. subtilis wt and yrrO mutant strains and analyzed for mo5U levels. Analysis of the individual tRNAs would also reinforce the observed decrease in mo5U since the effects in bulk tRNA are not large. A previously described oligonucleotide capture method (33, 34) was used to purify individual tRNAs from purified total tRNA isolated from both the wt and yrrO deletion strains. In many cases, the tRNAs were homogeneous after one round of affinity purification, as judged from the modification HPLC profile and PAGE analysis. As determined by PAGE (see Fig. S2 in the supplemental material) and HPLC analysis (Fig. 6), four tRNA species were sufficiently purified from both wt and yrrO mutant strains as follows: , , , and . Unmodified transcripts were used as standards, insomuch as the modifications do not affect the mobility greatly. The purity of tRNAThr(mo5UGU) is lower (Fig. S2, lane 6), perhaps due in part to a degradation product; however, HPLC analysis (Fig. 6) shows a high level of purity based on the absence of modifications that are found in the other tRNAs. Purification of tRNASer and tRNALeu has been unsuccessful in that HPLC traces showed multiple modifications not ascribed to those tRNAs (7, 8). Of the tRNAs that have been purified sufficiently, measurement of mo5U levels (Fig. 6) show particularly significant reductions in tRNAPro and tRNAVal (<20% relative to those of the wt), while tRNAThr retains 50% mo5U and tRNAAla mo5U levels are essentially unaffected. None of the other modifications in these purified tRNAs were found to vary significantly in amount between the two strains. More work will need to be done, but these initial experiments show that there is a significant degree of tRNA specificity associated with YrrO-mediated ho5U biosynthesis. The overall reduced level of mo5U appears to be the result of variable reduction of mo5U in each tRNA. A similar analysis in the B. subtilis yrrN mutant and E. coli yegQ mutant will be useful to confirm potential tRNA selectivity of this pathway.
HPLC profiles of enzymatic digests of individual tRNAs (ca. 6 μg each) purified from B. subtilis wt and yrrO mutant strains. The expected modifications for each tRNA are listed on the left for reference. Some residual deoxynucleosides remain after DNase treatment and gel filtration. Detection is by absorbance at 280 nm.
Peptidase U32 protein expression and initial characterization: YrrN and YrrO form a complex that is Fe-S cluster independent.
Heterologous expression of yrrN and yrrO in E. coli BL21(DE3) cells gives highly soluble protein in each case. The cell pellet containing overproduced His6-YrrO is a deep brown color while the pellet for His6-YrrN is not. After purification under aerobic conditions, His6-YrrO shows a deep brown colored band on a Ni-nitrilotriacetic acid (Ni-NTA) affinity column and retains its color after G-50 buffer exchange. Initial experiments with UV-visible (UV-Vis) spectroscopy under aerobic conditions of the purified YrrO shows absorbance characteristics consistent with an Fe-S cluster protein but the amount of iron is quite low, indicating that the bound iron is oxygen sensitive. Further characterization will be required under anaerobic conditions. Conversely, His6-YrrN is overproduced at a high level but is a colorless protein through each step of the purification process. This is consistent with the amino acid alignment of the two proteins in Fig. 2B that shows mutation of three of the four conserved cysteines. Unlike the different properties of YrrN and YrrO in B. subtilis, overproduction and purification of the four peptidase U32 proteins in E. coli shows that all four give brown colored proteins. This is intriguing, since YhbU and YhbV both appear to lack one or more of the highly conserved cysteines shown in the amino acid sequence alignment. Thus, these proteins may contain an alternative type of Fe-S cluster or have insertions or deletions that bring in cysteines to structural positions analogous to those of YegQ or RlhA.
Because the yrrN and yrrO genes are adjacent in an operon in B. subtilis and they are homologous, it is possible that they form a complex. To assess this hypothesis, mixtures of purified His6-YrrO and His6-YrrN were analyzed by native polyacrylamide gel electrophoresis under aerobic conditions. Figure 7 shows that YrrN migrates as a single band, while YrrO shows two major bands in the presence of 5 mM dithiothreitol (DTT). Incubating YrrO in the presence of increasing concentrations of YrrN shows the appearance of new bands of slower mobility that increase in proportion to the amount of YrrN added with a decrease in the two major YrrO bands. This suggests the formation of a YrrN-YrrO complex by possibly two YrrO species observed in the native gel. Addition of the iron-chelating agent 2,2′-dipyridyl (100 uM) had no effect on complex formation (data not shown), which is a further indication that the YrrN-YrrO complexes are not dependent on iron binding.
Native PAGE analysis shows evidence of a YrrN-YrrO complex. Increasing concentrations of His6-YrrN are incubated with 2 μM His6-YrrO in 30 mM Tris-glycine with 5 mM DTT (20 μl total volume) for 30 min at RT and then analyzed on a 10% nondenaturing polyacrylamide gel using 30 mM Tris-glycine, pH 7.5, as the buffer. Gel was stained with Coomassie blue. Lane 1, 2 μg bovine serum albumin; lane 2, 2 μg purified His6-YrrN; lane 3, 4 μg YrrN; lane 4, 2 μg purified His6-YrrO; lane 5, 2 μg YrrO plus 0.125 eq YrrN; lane 6, YrrO plus 0.25 eq YrrN; lane 7, YrrO plus 0.5 eq YrrN; lane 8, YrrO plus 1 eq YrrN; lane 9, YrrO plus 2 eq YrrN. Arrows show position of major (A) and minor (B) potential YrrNO complexes.
The yrrNO and yegQ genes cannot heterologously complement the function of each other in vivo.
Unlike the ability of B. subtilis yrrM to complement E. coli cmoB mutants (22), heterologous expression of yrrN and yrrO either individually or together in the E. coli yegQ deletion strain had no effect on cmo5U levels (Fig. 3B). Similarly, when yegQ is cloned into the pLIKE-rep plasmid, its expression in the B. subtilis yrrNO deletion strain in the presence of bacitracin is unable to affect mo5U levels (Fig. 4B). This suggests that additional species-specific proteins are likely required for the modification reaction. One possible explanation is that the ferredoxin YfhL is not able to shuttle electrons to the FeS cluster of the putative YrrN-YrrO complex when it is expressed in E. coli. Similarly, a protein with function analogous to YfhL in B. subtilis may be unable to productively interact with YegQ in that organism. The coexpression of both yegQ and yfhL in B. subtilis has not been attempted but may provide an answer for this hypothesis. It is also reasonable to expect that there could be other proteins involved in the pathway to ho5U synthesis that are required for complementation and do not have active orthologs or they are not active with YegQ. The possibility of tRNA substrate specificity being an issue is perhaps less likely due to high homology between the tRNA substrates in the two organisms.
DISCUSSION
The data presented in this work show that, in both E. coli and B. subtilis, a biosynthetic route similar to ho5C synthesis in rRNA exists that requires the action of peptidase U32 proteins and prephenate as a possible source of the hydroxyl group. In E. coli, the data are supportive for a single peptidase U32 gene, yegQ, involved in ho5U biosynthesis. The 50% reduction in cmo5U levels in the yegQ mutant is unchanged at extended growth times, and no further reduction in cmo5U is observed in a mutant that lacks all four of the yegQ-like proteins. In B. subtilis, the roles of the two peptidase U32 genes yrrN and yrrO are different. Each gene reduces mo5U formation by the same 50% when deleted, and the double mutant has no additional reduction in the modification level. There is also in vitro evidence that the two proteins form a complex that is independent of iron binding. Whereas E. coli YegQ (and presumably YrrO in B. subtilis) has four conserved cysteines that are each required for wt cmo5U (and hence ho5U) synthesis in vivo, some of the other homologs have mutations in these positions that result in either alternative Fe-S cluster structures (YhbU, YhbV) or the loss of cluster forming ability (YrrN). Deletion of aroD, iscS, yegQ, and the ferredoxin yfhL in E. coli and combination mutants of these genes produces a similar level of reduction in cmo5U in each case, which suggests that a non-Fe-S cluster and non-peptidase U32 protein-dependent pathway that utilize a different source for the hydroxyl than prephenate likely coexist. The alternate pathway likely shows unique tRNA substrate specificity, at least in B. subtilis.
While this paper was in review, Suzuki and coworkers reported the discovery of the alternative ho5U biosynthesis pathway via an elegant systematic approach to the use of bioinformatics (31). In addition to their finding that yegQ and yrrNO in E. coli and B. subtilis, respectively, are required for prephenate-dependent anaerobic hydroxylation, they also identified a rhodanese-like protein YceA (named TrhO) in E. coli (YbfQ in B. subtilis) that utilizes O2 as the substrate to synthesize ho5U. Their extensive phylogenetic analysis showed a surprisingly diverse arrangement of ho5U biosynthesis genes in nature, with some organisms harboring only one of the two pathways, while others, including E. coli and B. subtilis, utilize both pathways to enable ho5U synthesis under both aerobic and anaerobic conditions. The data presented in this work are in complete agreement with their findings on the prephenate-dependent pathway.
One of the unique findings in this work is the discovery of the novel ferredoxin YfhL as an additional requirement for the prephenate-dependent ho5U pathway in E. coli. The yfhL mutant (as well as a yfhL yegQ double mutant) showed the same reduced level of cmo5U in bulk tRNA as that in the yegQ and aroD mutants, which suggests that it is essential for the prephenate-dependent ho5U pathway. Ferredoxins are ubiquitous throughout nature yet generally are ill-defined in terms of their physiological roles and specific redox partners (32). YfhL is a member of the “Alvin” ferredoxin family, first identified in Allochromatium vinosum (35). These novel proteins contain two [4Fe-4S] clusters of widely differing and very low redox potential (E01 ∼ −650 mV; E02 ∼ −450 mV) due to unique structural motifs (36). Elsen et al. found evidence that the essential Alvin ferredoxin in Pseudomonas aeruginosa was likely not involved in the catabolism of aromatic compounds but instead that its gene had the constitutive expression characteristics of a housekeeping gene (37). It’s essentiality in that organism showed that other redox paralogs could not substitute for its essential function. Since many of these low potential ferredoxins exist in human pathogenic bacteria, they could be suitable as antibiotic targets. Since deletion of yfhL in E. coli appears to abolish prephenate-dependent ho5U synthesis, it is possible that this is a specific function of yfhL in vivo. Mechanistically, it is not clear why YegQ (TrhP) would require electrons to catalyze what is formally an oxidation reaction, unless the mechanism is similar to a number of radical-mediated oxidation reactions. Recent work by Booker and coworkers has shown that in Thermotoga maritima, a ferredoxin together with a ferredoxin reductase efficiently provide electrons to the Fe-S cluster bound to the radical-SAM enzyme MiaB in vitro to support its methylthiolation of tRNA (38). The role for the reduced ferredoxin in these enzymes is to transfer an electron to facilitate formation of the 5′-adenosyl radical that initiates thiolation at the C-2 of adenosine. Thus, the role for YfhL in ho5U synthesis may be to reduce an Fe-S cluster in YegQ for the formation of a radical species, such as a uridine-5-yl radical, that can combine with a hydroxyl radical from prephenate. Analysis of the E. coli flavodoxin/ferredoxin NADP reductase (fpr) gene for a possible requirement in ho5U formation has not yet been assessed but could be the physiological source of reducing equivalents to yfhL via NADPH. Additional studies under anaerobic conditions will be required to further elucidate the role of a YfhL-YegQ interaction and possible electron transfer between the two proteins as well as the in vitro reconstitution of the hydroxylation step.
In B. subtilis and other bacteria without yfhL orthologs, ferredoxins of a different type or flavodoxins may act analogously to provide electrons for ho5U formation. B. subtilis has one dedicated ferredoxin (Fer) and two flavodoxins (YkuN and YkuP) that could serve in this role, although all three proteins have previously been implicated in fatty acid desaturase activity in vivo (39) and they likely have additional redox roles. Interestingly, the ferredoxin/flavodoxin reductase is required for viability in B. subtilis (26). It is also possible that a unique redox protein exists that is specifically required for ho5U synthesis in this organism. Identification of the specific redox factors may facilitate in vitro reconstitution of ho5U activity.
Finally, during the search for evidence for an alternative independent pathway for ho5U synthesis in bacteria, a few organisms that lack peptidase U32 genes were screened for the presence of ho5U and its known derivatives in their tRNA. Data on modified nucleosides in tRNA for most organisms are lacking. However, recent work by Cao and Limbach using liquid chromatography-tandem mass spectrometry (LC-MS/MS) (40) has shown that Streptomyces griseus, which has no peptidase U32 genes in its genome, also lacks ho5U derivatives in its tRNA. A similar result has been confirmed in our laboratory for the closely related Streptomyces coelicolor A3(2) (my unpublished data). These organisms also appear to lack the newly discovered hydroxylase trhO, so they are expected to lack ho5U-related modifications. Initial results indicate that Lactobacillus casei (ATCC 393), which also lacks both trhP and trhO homologs, was found to contain no ho5U-related tRNA modifications. The alphaproteobacterium Novosphingobium capsulatum (ATCC 14666) has also been analyzed. This organism lacks peptidase U32 genes but does contain trhO as well as a homolog of the trmR methyltransferase. However, no mo5U could be detected. Analysis of larger quantity digests showed a very small amount (∼0.01 mol/mol tRNA) of cmo5U in its tRNA. This is an order of magnitude lower cmo5U modification level than that found in the tRNA of E. coli. Homology searches show that the N. capsulatum genome contains two weakly homologous genes to cmoA, in addition to trmR, but no close homolog of cmoB, which is required for cmo5U synthesis. Thus, one of the three methyltransferases is likely performing the function of the product of cmoB in this organism. These initial results, although limited, show that it may be difficult to predict based on homology alone which ho5U derivative is produced by an organism and to what degree each tRNA will be modified. Further identification and quantitation of these modifications in a variety of organisms will be useful to further refine the annotation of the genes required for their biosynthesis.
MATERIALS AND METHODS
General methods.
All strains were grown in LB medium (5 g/liter NaCl; Lennox) at 250 rpm and 37°C unless otherwise indicated. The following antibiotics were used with concentrations indicated: ampicillin (100 μg/ml), chloramphenicol (30 μg/ml), kanamycin (10 μg/ml for B. subtilis mutant strains and 30 μg/ml for E. coli plasmid maintenance), and erythromycin (1 μg/ml, used with 25 μg/ml lincomycin). Electrocompetent E. coli cells were prepared by harvesting cells from a 50-ml culture grown in LB to an A600 of 0.6 (4,000 rpm for 10 min at 4°C; SH-3000 rotor) and resuspending the cells at least three times in 40 ml of ice cold 10% glycerol followed by centrifugation at 4°C each time. The final cell pellet was suspended in 0.35 ml cold 10% glycerol, and 50 μl of cells were aliquoted into 1.5-ml tubes and stored at −80°C. Electroporation was performed using a BTX electroporation system with 1-mm gap cuvettes (BTX model 610). Electroporation instrument settings were 2.5 kV resistance, 50 μF capacitance timing, 129 Ohm resistance timing, and a charging voltage of 1.4 kV. Cells were suspended in expression recovery medium (Lucigen) immediately after electroporation and grown at the desired temperature for 1 h prior to plating on selective medium. Bacillus subtilis competent cells were prepared and transformed with DNA according to Koo et al. (26).
Generation and verification of deletion strains.
A complete list of deletion strains obtained or generated in this study is found in Table 1. Bacillus subtilis single-gene deletion strains were obtained from the Bacillus Genetic Stock Center. The yrrNO double-knockout strain was prepared by replacing the yrrNO genes with a kanamycin resistance cassette amplified from plasmid pDR240a using the procedure of Koo et al. (26). Single gene deletion strains of E. coli (with the exception of the yhbV mutant) were from the Keio collection (27) obtained through the E. coli Genetic Stock Center. The yhbV single mutant and all multiple deletion strains were prepared by the method of Datsenko and Wanner (28) using either chloramphenicol or kanamycin gene replacement using pKD46-mediated double crossover. Removal of the antibiotic resistance cassette was mediated by pCP20 as described (28). All mutant strains were verified by PCR using both internal and external primers to either the antibiotic resistance genes or the wt genes to ensure loss of the wt gene in the genome as well as correctly placed insertion of the antibiotic resistance gene. Primers for all mutant generation and verification are listed in Table 2.
TABLE 1
Strains used in this study
| Straina | Genotype or characteristic(s) | Source(s) |
|---|---|---|
| BW25113 | E. coli Keio reference strain | CGSC |
| JW2066 | yegQ::kan | Keio collection/CGSC |
| JW1431 | rlhA::kan | Keio collection/CGSC |
| JW3127 | yhbU::kan | Keio collection/CGSC |
| CL5120 | yegQ::cat | This work |
| CL5131 | yegQ<>frtb | This work |
| CL5133 | yhbV::cat | This work |
| CL5136 | yegQ::cat yhbU::kan | This work |
| CL5140 | yegQ::cat rlhA::kan | This work |
| CL5142 | yhbU::cm rlhA::kan | This work |
| CL5150 | yegQ<>frt yhbUV::cat rlhA::kan | This work |
| JW2514 | iscS::kan | Keio collection/CGSC |
| JW1683 | aroD::kan | Keio collection/CGSC |
| CL5161 | aroD::kan yegQ::cat | This work |
| JW2546 | yfhL::kan | Keio collection/CGSC |
| CL5164 | yfhL::kan yegQ::cat | This work |
| Bacillus subtilis 168 | trpC2 (B. subtilis reference strain) | BGSC |
| BKE27360 | yrrM::erm | BGSC |
| BKK27360 | yrrM::kan | BGSC |
| BKE27350 | yrrN::erm | BGSC |
| BKK27350 | yrrN::kan | BGSC |
| BKE27340 | yrrO::erm | BGSC |
| BKK27340 | yrrO::kan | BGSC |
| CL5145 | yrrNO::kan | This work |
| CL5149 | yrrNO::erm | This work |
| BKK25660 | aroD::kan | BGSC |
Cloning and complementation analysis of genes required for ho5U synthesis.
For complementation of E. coli xo5U-deficient mutant strains, E. coli yegQ and yfhL, as well as B. subtilis yrrN and yrrO, were each cloned into plasmid pBAD33 (41) using KpnI and HindIII (primers for all cloning and mutant verification are given in Table 2). Electrocompetent E. coli mutant strains were transformed with the corresponding plasmid and streaked on LB agar plates with chloramphenicol (30 μg/ml). Colonies were grown in LB with chloramphenicol and gene expression was initiated by addition of 0.1% l-arabinose at early log phase (A600 = 0.1). When cells reached early stationary phase (A600 = 0.8 to 1.0), they were harvested by centrifugation and tRNA was isolated and analyzed for xo5U levels as described above. For complementation of B. subtilis mo5U-deficient mutant strains, the pLIKE system was used (25). The pLIKE-rep plasmid contains a beta-lactamase gene for maintenance with ampicillin in E. coli and an erythromycin resistance cassette for propagation in B. subtilis. The yrrN and yrrO genes from B. subtilis and the yegQ gene from E. coli were cloned into pLIKE-rep using XbaI and HindIII as N-terminal and C-terminal primers, respectively (see Table 2).
Isolation and purification of total tRNA.
Isolation of tRNA from both B. subtilis and E. coli was performed using the TRIzol reagent. Cell pellets from 50-ml cultures were resuspended in 10 mM Tris, pH 8, and treated with 15 mg of lysozyme in a 13-ml polypropylene tube at 37°C with shaking for 20 min. TRIzol (4 ml) was added, and the mixture was vortexed until homogeneous and allowed to stand at room temperature for 10 min. Chloroform (0.8 ml) was then added, and the mixture was shaken vigorously for 15 s and allowed to stand for an additional 10 min. After centrifugation (20 min at 10,000 rpm Sorvall SS-34 rotor at 4°C), the top aqueous layer was carefully transferred to a new polypropylene tube. Aqueous sodium acetate (0.35 ml of 3M) was added followed by cold ethanol (∼9 ml to top of tube), and the tube was vortexed and stored at –20°C for 2 h to overnight to precipitate RNA. The precipitated RNA was washed with 2 ml of cold 70% aqueous ethanol, air dried for 10 min, and then dissolved in 2 ml of R200 buffer (10 mM Tris-phosphate [pH 6.3], 200 mM KCl, 15% ethanol). The crude tRNA was purified on an AX 500 column (Macherey-Nagel) as described (15) with the following modifications. The column was first washed with R1500 buffer and then equilibrated with R200 buffer. The RNA solution was added to the equilibrated column, which was then washed with 6 ml of R200 buffer and 4 ml of R600 buffer, and the tRNA was eluted with 7 ml R1000 buffer into a 13-ml polypropylene tube. Isopropanol (4.9 ml) was added, and the tube was vortexed and allowed to stand at room temperature (RT) for 30 min. The tRNA was isolated by centrifugation (Sorvall SS-34 rotor at 14,000 rpm at 4°C) for 30 min, and the pellet was washed with 2 ml of cold 70% ethanol, dried, and dissolved in water. A typical yield of tRNA from a 50-ml culture at late log phase was 0.5 mg. Denaturing gel electrophoresis showed no significant rRNA contamination. The tRNA purified in this manner was the starting material for the enrichment of single tRNA species.
Analysis of total tRNA from wt and mutant strains.
Modification levels of AX 500-purified tRNA from the different strains were analyzed by enzymatic digestion and HPLC analysis of the digests. The method of Gehrke and Kuo (42) was used to digest tRNA. Two different protocols were used. To analyze for cmo5U, 50 μg of tRNA was digested with 3 units of nuclease P1 (Millipore-Sigma) in a total volume of 90 μl of 30 mM sodium acetate (NaOAc), 0.2 mM zinc diacetate [Zn(OAc)2] at 37°C for 1.5 h, and then 10 μl of morpholinepropanesulfonic acid (MOPS) (or Tris) buffer, pH 8.3, and 0.5 unit of bacterial alkaline phosphatase (Worthington) were added. The mixture was incubated at 37°C for 4 h to fully hydrolyze mcmo5U to cmo5U. For the analysis of mo5U and ho5U, a “quick” digestion protocol was used that employed 50 μg tRNA in 100 μl of 30 mM NaOAc, 0.2 mM Zn(OAc)2, pH 6, with the above amounts of both nuclease P1 and alkaline phosphatase incubated at 37°C for 1.5 h. This quick digestion avoided the production of a previously described degradation product that comigrates with ho5U in the HPLC analysis (15).
HPLC analysis was essentially as previously described (15) using a Develosil RP-Aqueous C30 column (Phenomenex) with the following modifications. A binary gradient was used with buffer A consisting of 50 mM ammonium phosphate, pH 5.3, and buffer B consisting of buffer A with 20% (vol/vol) methanol. UV detection was used at 280 nm, and quantitation was based on peak integration with standardization by comparing the peak areas of known quantities of synthetic standards of mo5U (Millipore Sigma) and ho5U and cmo5U (synthesis described below). Certain nucleosides (mo5U, cmo5U) isolated from mutant strains were also confirmed for correct mass using mass spectrometry of isolated HPLC peak fractions. Isolated ho5U, cmo5U, and mo5U were also analyzed by coinjection with synthetic standards in a different chromatographic system (Supelco LC-18S column using binary gradient with 5 mM ammonium acetate as buffer A and 40% aqueous acetonitrile as buffer B).
Enrichment of single tRNA species from wt and mutant strains.
Individual tRNAs were isolated from AX 500-purified tRNA using the batchwise method of Tsurui et al. (33) with the buffer system of Suzuki and Suzuki (34), as modified by Kohrer et al. (43). Biotinylated oligonucleotides complementary to residues 1 to 37 of the targeted tRNA were used to bind individual tRNAs. These oligonucleotides were immobilized by adding 27 nmol biotinylated DNA to 0.3 ml (settled volume) of streptavidin-agarose (85-nmol/ml binding capacity; EMD) in binding buffer of 10 mM HEPES, pH 7.5, 400 mM NaCl, and 5 mM EDTA. The mixture was rotated at RT for 1 h and then transferred to an empty Bio-Rad Econo-Column with frit and washed with 4 × 1 ml binding buffer to remove unbound oligonucleotide. From the A260 of the washes, the amount of bound oligonucleotide was estimated at 95%. The resin was then washed with 1× binding buffer (34) consisting of 30 mM HEPES (pH 7.5), 1.2 M NaCl, and 15 mM EDTA. A total of 4 mg of purified bulk tRNA was used as the starting material for the isolation. Thus, 4 mg AX 500-purified tRNA from either wt or mutant strain was dissolved in binding buffer and added to the 0.25 ml DNA-bound resin in a total volume of 1.2 ml. The mixture was heated to 70°C in a heating block for 30 min and then slow cooled over 30 min to 30°C. After incubation at 30°C for 30 min, the resin was transferred to a column and washed with 4 × 1 ml 0.5× binding buffer preequilibrated to 37°C (34). The first two 1-ml washes were precipitated with 2.5 vol cold ethanol and reserved for subsequent tRNA isolations. The resin in the column was then further washed with 2 × 0.4 ml of 0.05× (1/20) binding buffer and transferred to a 1.5-ml tube. The tube was centrifuged for 30 s (10,000 rpm in microcentrifuge at RT), and the supernatant was removed. The tRNA-bound resin was then eluted with 4 × 0.45 ml of 0.017× (1/60) binding buffer preequilibrated to 65°C. To each elution fraction (∼0.4 ml) was added 40 μl of 5 M NaCl and 1 ml of cold ethanol, and the eluted tRNA was stored at –20°C overnight. The typical yield of tRNA was 20 to 40 μg in fraction 1 and 10 to 20 μg in fraction 2. After each round of tRNA isolation, the isolated and precipitated flow through and washes containing the nonbinding tRNA were pooled and precipitated for the next round of tRNA isolation. Purity of the individual tRNAs was estimated by PAGE analysis and HPLC modification profile. For the gel analysis, 0.5 μg of tRNA was loaded onto denaturing polyacrylamide minigels using urea as denaturant (SequaGel; National Diagnostics). Gels were stained with ethidium bromide in Tris-acetate-EDTA (TAE) buffer, and RNA was visualized by UV transillumination. Unmodified individual tRNA transcripts were used as estimates of migration standards. HPLC analysis of tRNAs as described above was used to assess if the isolated individual tRNAs showed only the expected modification profile (7, 8), which was also an indication of purity. Initial analysis showed that a significant amount of the DNA oligonucleotides coelute with the eluted tRNA; therefore, 15 μg of each tRNA was treated with 3 units of RQ1 DNase (Promega) in recommended buffer in a total volume of 20 μl for 1 h at 37°C. The tRNA was then applied to a 0.8-ml Sephadex G-50 spin column using empty Micro Bio-Spin columns (Bio-Rad). The G-50 columns were centrifuged at 7,000 rpm in an Eppendorf microcentrifuge for 1 min to remove water, and then the reaction mixture was loaded onto the center of the resin and the column was centrifuged again to separate the tRNA from the buffer and hydrolyzed DNA. The purified tRNA was then digested and analyzed by HPLC as described above. For each enriched tRNA species, xo5U species were quantified by absorbance at 280 nm and the ratio of xo5U/Ψ was recorded for mutant strains relative to that of the wt.
Gel mobility shift experiments.
The presence of a YrrN-YrrO protein complex was analyzed using nondenaturing PAGE with Tris-glycine buffer. Briefly, mixtures of 2 μg of N-terminal His6 fused B. subtilis YrrO (His6-YrrO) with increasing amounts of His6-YrrN (0.125 to 2 molar equivalents) in 30 mM Tris-glycine, pH 7.5, and 10 mM DTT (10 μl total volume) were incubated at RT for 15 min. Each binding mixture was then loaded into an individual lane on a 10% polyacrylamide gel using 30 mM Tris-glycine, pH 7.5, as running buffer. Proteins were visualized using Coomassie brilliant blue R200 and destained with 10% (vol/vol) acetic acid and 10% (vol/vol) methanol in water. Native gels constructed for tRNA binding analysis consisted of 8% polyacrylamide-bisacrylamide (19:1) in either 1× Tris-borate-EDTA (TBE) or 30 mM Tris-glycine buffer at pH 7.5 containing 2 mM MgCl2.
Preparation of synthetic ho5U and cmo5U.
The synthesis of ho5U used a minor modification of the procedure of for the preparation of 5-hydroxy-2′-deoxyuridine (44). The crude material was purified by silica gel chromatography using acetonitrile-water (9:1) as eluent. This material was used to prepare cmo5U as follows. To a solution of 10.5 mg (40 μmol) ho5U in 260 μl H2O in a 1-ml brown glass vial was added 40 μl (80 μmol) of 2 N NaOH at room temperature to give a pH of >9. To this mixture, 7.5 mg (40 μmol) of iodoacetic acid was added, and the reaction was mixed by vortexing and allowed to stand overnight. Two additional aliquots of 7.5 mg iodoacetic acid and 40 μl 2 N NaOH were added at 24-h intervals to maintain the pH of >9. After a total of 72 h, HPLC showed the reaction was approximately 70% complete. The desired product was purified by HPLC on a Supelco LC-18 semiprep column (5 μm, 25 cm by 10 mm) using 5 mM ammonium acetate, pH 5.3, as buffer A and 40% acetonitrile in water as buffer B with the following step gradient: t = 0 to 13 min 0% B; t = 13 to 20 linear gradient of 0% to 100% B. Flow rate was 3 ml/min, and cmo5U was detected at 280 nm. The final yield of cmo5U was 55% and was >99% pure by analytical HPLC (tR = 35.5 min; Supelco LC-18s column; same gradient as described for purification; tR = 33.5 min RP-Aqueous C30 column, gradient described above for analysis of tRNA digests). UV λmax = 278; 1H NMR 500 MHz (D2O) δ 7.53 (s, 1H), 5.98 (t, 1H, J = 4.0 Hz), 4.39 (s, 2H), 4.36 (m, 1H), 4.27 (m, 1H), 4.17 (m, 1H), 3.92 (AB part of ABX pattern, 2H). HRMS calculated for C11H14N2O9(H+): 319.07721. Found: 319.0765.
ACKNOWLEDGMENTS
I thank Daniel Ziegler of the Bacillus Genetic Stock Center for helpful discussions on preparing deletion mutants and using expression plasmids in B. subtilis.
I gratefully acknowledge the School of Pharmacy at the University of Wisconsin-Madison for financial support.
Footnotes
Supplemental material for this article may be found at https://doi.org/10.1128/JB.00433-19.